热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Pacific Blue™ anti-mouse I-A/I-E Antibody
产品名称：
Pacific Blue™ anti-mouse I-A/I-E Antibody
产品类别：
抗体
产品编号：
107619
产品应用：
107619
[价格]
规格 价格 库存
25µg ￥ 1128 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue? under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The I-A/I-E antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue? has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue? conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Application References

(PubMed link indicates BioLegend citation)
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  18. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  4. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  5. Israelow B, et al. 2020. bioRxiv. . PubMed
  6. Slocombe T, et al. 2013. J Immunol. 191:3128. PubMed
  7. Zahner S, et al. 2011. J Immunol. 187:5069. PubMed
  8. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  9. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  10. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  11. Venanzi E, et al. 2007. J Immunol. 179:5693. PubMed
  12. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  13. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  14. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  15. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  16. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  17. Dupont C, et al. 2015. J Immunol. 195: 4369 - 4377. PubMed
  18. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  19. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  20. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
  21. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  22. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  23. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  24. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  25. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  26. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  27. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  28. Nakajima A, et al. 2014. PLoS One. 9:105904. PubMed
  29. Bunting M, et al. 2013. Blood. 121:118. PubMed
  30. Holly Bachus et al. 2018. Immunity. 50(1):225-240 . PubMed
  31. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  32. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  33. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  34. Yang M, et al. 2021. Cancer Immunol Immunother. 70:2467. PubMed
  35. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  36. Fontinha D, et al. 2015. PLoS One. 10: 0142540. PubMed
  37. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  38. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  39. Steiger S, et al. 2015. J Immunol. 195: 5495 - 5502. PubMed
  40. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  41. Huang S, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.75. PubMed
  42. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  43. Jaensson E, et al. 2008. J Exp Med. 205:2139. PubMed
  44. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  45. Chen Z, et al. 2016. Nat Commun. 7:11596. PubMed
  46. Kim M, et al. 2018. Immunity. 49:151. PubMed
  47. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  48. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  49. Eun S, et al. 2015. J Immunol. 194:134. PubMed
  50. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  51. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  52. Hu M, et al. 2019. Nat Commun. 10:3031. PubMed
  53. Schulz O, et al. 2009. J Exp Med. 206:3101. PubMed
  54. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  55. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  56. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  57. McCarthy N, et al. 2015. J Immunol. 195: 2675-2682. PubMed
  58. Zhang H et al. 2018. Cell. 175(5):1244-1258 . PubMed
  59. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  60. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  61. Korin B, et al. 2020. Sleep. :43. PubMed
  62. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  63. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  64. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  65. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  66. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  67. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  68. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  69. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  70. White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed
  71. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  72. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  73. Schuijs M, et al. 2016. PLoS One. 11: 016188. PubMed
  74. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  75. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  76. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  77. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  78. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  79. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  80. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  81. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_493528 (BioLegend Cat. No. 107619) AB_493527 (BioLegend Cat. No. 107620)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线